Gylden Pharma
Develops intradermal drug-delivery and immune-activation platforms for migraine treatment, vaccines and oncology
Highlights
- New on EvolcAdded 2026-11-08
About Gylden Pharma
Gylden Pharma develops precision intradermal therapeutics using titanium microneedle and gold nanoparticle platforms. Its lead asset, Zograine, is a zolmitriptan microneedle patch for acute migraine; its pipeline also includes vaccine and oncology programs.
The company is headquartered in Abingdon, United Kingdom, and was founded in 2016. Its pipeline includes programs at clinical, preclinical and discovery stages.
Product: Titanium microneedle drug-delivery and gold nanoparticle immune-activation platforms, including a migraine patch and vaccine programs.
Jobs at Gylden Pharma
Leadership
- Frank Tufaro · Chief Executive OfficerSource: company website
- Laurens Rademacher · Managing DirectorSource: company website
More biotech & pharma companies
hameln pharma
Generic injectable medicines for hospitals, pharmacies and palliative care in more than 45 countriesNew on EvolcRemote-friendlyHistologix
GLP- and GCP-compliant tissue analysis and histopathology services for pharmaceutical and biotechnology companiesNew on EvolcHorizon Discovery Group
Gene-editing reagents, engineered cell lines and reference standards for life sciences research and diagnosticsNew on EvolcHvivo Services
Early-phase clinical trials, human challenge studies and lab services for biopharma and biotech sponsorsNew on EvolcHyfacol
Medical-grade collagen manufacturing platform for advanced wound care and guided bone regeneration productsYoung companyNew on EvolcHypha Discovery
Specialist CRO making drug and agrochemical metabolites, purifying compounds and running MetID studies for pharma clientsNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- ApacheHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.